Allurion Technologies Inc. (ALUR)
OTCMKTS · Delayed Price · Currency is USD
0.0021
+0.0011 (110.00%)
At close: Nov 10, 2026
Allurion Technologies Revenue
Allurion Technologies had revenue of $2.95M in the quarter ending March 31, 2026, a decrease of -47.19%. This brings the company's total for the last twelve months to $12.60M, down -55.49% year-over-year. In the year 2025, Allurion Technologies had annual revenue of $15.23M, down -52.57%. That makes Allurion Technologies the 36,314th largest company in the world by revenue and 4,765th in the United States.
Revenue (ttm)
12.60M
Revenue Growth
-55.49%
P/S Ratio
0.00
Revenue / Employee
314.93K
Employees
41
Market Cap
617.00
Revenue by Geography
- ALL Other Countries 11.24M 73.8%
- Spain 2.15M 14.1%
- Italy 1.84M 12.1%
Fiscal year ended Dec 31, 2025 See the full Allurion Technologies breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.23M | -16.88M | -52.57% |
| Dec 31, 2024 | 32.11M | -21.36M | -39.94% |
| Dec 31, 2023 | 53.47M | -10.74M | -16.73% |
| Dec 31, 2022 | 64.21M | 25.97M | 67.91% |
| Dec 31, 2021 | 38.24M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DIH Holding US | 62.86M |
| Minerva Surgical | 51.69M |
| STRATA Skin Sciences | 30.70M |
| ThermoGenesis Holdings | 9.61M |
| Avitar | 2.66M |
| Southern Home Medical | 603.37K |
| Motus GI Holdings | 327.00K |
| Enchanted World | 303.00K |
Allurion Technologies News
- 4 months ago - Allurion Advances Plan to Re-List - Business Wire
- 5 months ago - Allurion announces ‘successful early traction’ in US. Allurion Program launch - TheFly
- 5 months ago - Allurion Announces Strong Start to U.S. Launch with Exceptional Early Outcomes and Growth Momentum - Business Wire
- 6 months ago - Allurion Technologies treats first commercial patients in the U.S. - TheFly
- 6 months ago - Allurion Treats First Commercial Patients in the United States, Marking Major Milestone - Business Wire
- 8 months ago - Allurion Technologies appeals NYSE decision to initiate delisting proceedings - TheFly
- 8 months ago - Allurion Advances Plan to Regain Listing Compliance - Business Wire
- 8 months ago - Allurion Begins Training and On‑Boarding of U.S. Accounts, Marking Major Milestone in Expansion Strategy - Business Wire